阿德里亚米辛诱导的脏病模型:阐明CKD病理生理学和推进治疗策略
Masaki Watanabe1, Hayato R Takimoto1, Nobuya Sasaki1
1Laboratory of Laboratory Animal Science and Medicine, School of Veterinary Medicine, Kitasato University, 35-1 Higashi-23, Towada, Aomori 034-8628, Japan.
Experimental animals
|November 24, 2024
概括
阿德里亚米辛诱导脏病 (AN) 模型通过模仿人类疾病特征来帮助慢性病 (CKD) 研究. 这个模型有助于评估潜在的治疗方法,并开发更好的病诊断工具.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 阿德里亚米辛诱导脏病 (AN) 模型对于研究慢性脏病 (CKD) 是至关重要的.
- 这个模型复制了人类关键的CKD病理,包括蛋白尿,细胞损伤和纤维化.
- 遗传因素,如Prkdc基因突变,影响AN的发展和严重程度.
研究的目的:
- 在CKD研究中审查AN模型的方法,特征和应用.
- 讨论在AN模型中测试的治疗干预措施及其保护作用.
- 突出模型的局限性和未来的研究方向,包括基因工程和生物标志物发现.
主要方法:
- 关于动物AN模型生成和表征的现有文献的综述.
- 对AN模型的病理生理学和分子特征的分析.
- 在CKD的AN模型中测试的治疗剂的评估.
主要成果:
- 该AN模型有效地模仿了人类CKD的特征,如蛋白尿和血球样硬化.
- 遗传变异,特别是Prkdc,影响AN易感性和毒性.
- 经过测试的疗法 (ACE抑制剂,皮质类固醇,SGLT2抑制剂) 在AN模型中显示出潜在的保护作用.
结论:
- 该AN模型是了解CKD和评估治疗的宝贵工具.
- 限制包括阿德里亚米的全身毒性和模型可变性,需要仔细解释.
- 未来使用CRISPR-Cas9等先进遗传工具的研究将提高模型的可靠性,并有助于早期CKD诊断和向治疗的生物标志物发现.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
01:11Renal Failure: Dose Adjustments
64
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
64
01:10Nephrons
2.2K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.2K
01:17Factors Affecting Renal Clearance: Renal Impairment
54
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
54
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
455
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
455
01:22Heart Failure Drugs: Diuretics
343
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
343